ViroGates A/S announces the first order from a new clinical routine customer in Greece. The customer is a hospital located in the Athens area. The hospital is a public hospital with more than 700 beds and is one of Greece's leading university hospitals. The hospital has placed the first order of suPARnostic? TurbiLatex for its Roche cobas 701 system. The hospital has previously also been a participant in the SAVE-MORE COVID-19 study using the suPARnostic? Quick Triage product.